Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

CRX 100

Next Previous
Drug Profile

CRX 100

Alternative Names: CRX-100

Latest Information Update: 28 Aug 2024

Price :
$50 *
Note:
  • Adis is an information provider. We do not sell or distribute actual drugs.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase.
  • A link to download a PDF version of the drug profile will be included in your email receipt.

At a glance

  • Originator BioEclipse Therapeutics
  • Class Antineoplastics; Cell therapies; Immunotherapies; Oncolytic viruses
  • Mechanism of Action Cell death stimulants; Cytotoxic T lymphocyte stimulants
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No
  • New Molecular Entity No

Highest Development Phases

  • Phase I Solid tumours
  • Preclinical Ovarian cancer

Most Recent Events

  • 28 Aug 2024 Phase I development is ongoing in Solid tumours (Late stage disease, Metastatic disease,Second line therapy or greater) in USA (IV, Infusion) (bioeclipse pipeline, August 2024)
  • 28 Aug 2024 Preclinical development is ongoing USA (IV, Infusion) (bioeclipse pipeline, August 2024)
  • 08 Apr 2022 Safety, efficacy and pharmacodynamics data from a phase I trial in Solid tumours presented at the 113th Annual Meeting of the American Association for Cancer Research (AACR-2022)

You need to be a logged in or subscribed to view this content

Request demo (opens in a new window)
If your organization or you do not have a subscription, try one of the following: If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top